Lucis vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionLucisIsomorphic Labs
ApproachBiomarker testing + daily coaching (consumer)AI-driven drug discovery (partnerships)
Target UserProactive health individuals in EuropePharma companies, researchers
Key Feature110+ biomarker panel, wearable integrationAlphaFold-based Drug Design Engine
PricingPaid subscription (annual/bi-annual testing)Contact sales
GeographyEurope (EU/UK labs)Global (pharma partners)
Regulatory StatusGDPR, ISO 27001, HDS certifiedN/A (research partnerships)

Isomorphic Labs is for pharma companies seeking AI-powered drug discovery; Lucis is for individuals in Europe wanting deep biomarker insights. The two tools serve entirely different needs and cannot be substituted. Choose based on your role: enterprise partnership vs personal preventive health.

Lucis
Lucis

A European preventive-health membership pairing twice-yearly lab testing across 11 body systems with a personalized action protocol.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Paid
Contact Sales
Plans
€490/year
—
Popularity
5 views
7.5k views
Skill Level
Beginner-friendly
Advanced
API Available
Platforms
Web
—
Categories
🏋️ Fitness & Nutrition
🧬 Drug Discovery & Life Sciences
Features
First assessment covering 100+ biomarkers across 11 body systems
Six-month follow-up panel of 60+ biomarkers for trend tracking
Blood, urine, and saliva collected in a single lab visit
450+ partner labs across Europe and the UK
Home collection kit for members in France
Lab draws at partner locations in the UK and Portugal
Each body system scored with plain-language explanations
Simplified wellness indices for inflammation, energy, metabolism, and hormones
Personalized protocol covering nutrition, supplementation, sleep, and physical activity
Protocol also addresses environment and mental health factors
Wearable sync with Oura, Garmin, Withings, and Strava
Private dashboard for exploring results and tracking progress between checks
Health questionnaire capturing goals, symptoms, history, and lifestyle
Educational content with evidence-strength ratings
Add-on tests to dig deeper into a specific body system
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO
Integrations
Oura
Garmin
Withings
Strava

Who should pick which

  • Pharma R&D executive
    Pick: Isomorphic Labs

    Isomorphic Labs offers AI-driven drug discovery partnerships leveraging AlphaFold, directly targeting late-stage pipeline acceleration.

  • European health-conscious professional
    Pick: Lucis

    Lucis provides comprehensive biomarker testing, coaching, and wearable integration to optimize health and energy, ideal for proactive individuals.

  • Academic researcher in digital biology
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine and simulation capabilities are suited for large-scale research collaborations.

  • Longevity-focused individual in EU/UK
    Pick: Lucis

    Lucis' biannual testing and trend tracking align with longevity goals; its European focus ensures lab access.

Frequently Asked Questions

Lucis vs Isomorphic Labs: which should you choose?

Isomorphic Labs is for pharma companies seeking AI-powered drug discovery; Lucis is for individuals in Europe wanting deep biomarker insights. The two tools serve entirely different needs and cannot be substituted. Choose based on your role: enterprise partnership vs personal preventive health.

Can I use Isomorphic Labs as an individual researcher?

No. Isomorphic Labs only partners with pharma companies; it does not offer APIs or self-service tools.

Does Lucis offer genetic testing?

No. Lucis tests blood, urine, and saliva biomarkers (110+ markers) but not DNA/genetics according to provided data.

Are Isomorphic Labs' models available to the public?

Not directly. Their Drug Design Engine is proprietary and used within pharma partnerships.

Can I use Lucis outside Europe?

No. Lucis labs are in EU/UK only; home collection kit only in France.

What recent funding has Isomorphic Labs received?

A $600M external investment round in 2025 and a Series B in February 2026 (amount undisclosed).

Does Lucis integrate with Apple Health?

No. Integrations listed: Oura, Garmin, Withings, Strava.

Is Isomorphic Labs a software product?

No. It's a drug discovery company; its AI tools are used internally and via collaborations.

How quickly does Lucis deliver results?

Results are available ~1 month after lab test.

More Lucis or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026